Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents: 3 (Enzyme Inhibitors Series) - Image 1

£230.00

CRC Press Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents: 3 (Enzyme Inhibitors Series)

Name: Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents: 3 (Enzyme Inhibitors Series)
Brand: CRC Press
Price: 230.0 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£230 today · previous high £230 · all-time low £35

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 618 days • 618 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 618 days • 3 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £191-230 (314 days, 50.8%)

Price range: £35 - £230

Price levels: 3 price ranges over 618 days

Description

One of the few books to cover all aspects of cyclin-dependent kinases (CDKs), Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents provides an overview of CDKs as molecular and functional entities, their involvement in different disease processes, and their potential for pharmacological modulation. With contributions from the top international researchers in the field, the book takes a contemporary approach to study the importance of rational drug design and knowledge-based therapeutics in relation to CDKs. The first two sections of the book discuss the integration of cell cycle control pathways, opportunities for targeting, targets of inhibitors, and the evaluation of CDK inhibitors, exploring topics such as the in vivo function of CDKs in normal homeostasisand tumor development and the structural biology of CDKs. The third section examines the design, development, and chemistry of small molecule CDK inhibitors, with discussions ranging from the early-stage discovery of new chemical entities with a capacity to inhibit CDKs to late-stage compounds in clinical development. The final section assesses the current status of CDK inhibitors in clinical trials, the therapeutic deployment challenges of small molecule inhibitors, and the future development of CDK inhibitors as anticancer agents. The field of drug development is at a critical point in terms of understanding the availability, advantages, and drawbacks of CDKs as therapeutic targets for small molecules. Providing the most up-to-date, in-depth coverage available in a single volume, Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents surveys the success of the agents developed thus far, the possibility of new routes to more selective inhibitors, and the growing appreciation of critical, therapeutic issues. Review "Smith and Yue have done an admirable job with this volume. There is a clear logic in the arrangement of the chapters. The introductory chapter is well suited to readers who are not familiar with this particular topic. Jargon is kept to a bar minimum . . . This highly readable volume should serve to get newcomers to the field up to speed quite quickly." – D. Eric Walters, Department of Biochemistry and Molecular Biology, Rosalind Franklin University of Medicine, in Journal of Medicinal Chemistry, 2007, Vol. 50, No. 19 "Providing up-to-date, in-depth coverage in a single volume, Inhibitors of Cyclin-dependent Kinases as Anti-Tumor Agents surveys the success of the agents developed thus far, the possibility of new routes to more selective inhibitors, and the growing appreciation of critical, therapeutic issues." – In Anticancer Research, Sept/ Oct 2007, Vol. 27, No. 5A

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 0849337747
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 25 October 2006
Listed Since: 23 December 2006

Barcode

No barcode data available

CRC Press Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents: 3 (Enzyme Inhibitors Series)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Carbohydrates as Drugs: 12 (Topics in Medicinal Chemistry, 12)

Therapy of Viral Infections: 15 (Topics in Medicinal Chemistry, 15)

Taste and Smell: 23 (Topics in Medicinal Chemistry, 23)

Taste and Smell: 23 (Topics in Medicinal Chemistry, 23)

Atypical Elements in Drug Design: 17 (Topics in Medicinal Chemistry, 17)

Chemokines: Chemokines and Their Receptors in Drug Discovery: 14 (Topics in Medicinal Chemistry, 14)

Chemokines: Chemokines and Their Receptors in Drug Discovery: 14 (Topics in Medicinal Chemistry, 14)

Humana Optimization in Drug Discovery: In Vitro Methods Book

High Throughput Screening Methods: Evolution and Refinement: Volume 1 (Chemical Biology)

Kinase Screening and Profiling: Methods and Protocols: 1360 (Methods in Molecular Biology, 1360)

Chemical Biology: Methods and Protocols: 1263 (Methods in Molecular Biology, 1263)

Medicinal Chemistry of Anticancer Drugs

Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development

Cancer-Leading Proteases: Structures, Functions, and Inhibition

Small Molecules for Cancer Treatment

Development of In-Tether Carbon Chiral Center-Induced Helical Peptide: Methodology and Applications (Springer Theses)

Development of In-Tether Carbon Chiral Center-Induced Helical Peptide: Methodology and Applications (Springer Theses)

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry and Pharmacology of Anticancer Drugs

Chembiomolecular Science: At the Frontier of Chemistry and Biology

Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development)

Protein-Protein Interactions: 8 (Topics in Medicinal Chemistry, 8)

Wiley - Contemporary Accounts in Drug Discovery and Development

Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad